Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...

This is the first time a regulator has confirmed the side effect. Read more at straitstimes.com. Read more at ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for weight ...